EBRD places fourth issue of dram coupon bonds worth AMD 2 billion

YEREVAN, July 30. /ARKA/. The European Bank for Reconstruction and Development has successfully placed the fourth issue of dram coupon bonds (EBRDB4) worth AMD 2 billion with a floating interest rate at NASDAQ OMX Armenia, the press office of the stock exchange reported on Wednesday.

The size of a coupon is equal to the cost of the central bank’s six-month bonds plus 0.25% of margin for the next coupon repayments. Yield is set at 12.0328%.

The underwriter of the bonds is Ameriabank and buyers are three members of the stock exchange.
NASDAQ OMX Armenia (former Armenian Stock Exchange, Armex), was established in 2001 as a voluntary merger of broker (dealer) companies.

In January 2008, Nordic exchange operator OMX Group acquired 100% of shares of the Armenian Stock Exchange (Armex) and the Central Depository of Armenia (CDA). After NASDAQ and OMX merged in March 2008, Armex and CDA have become fully owned by the NASDAQ OMX Group, Inc.

On January 27, 2009, Armenian Stock Exchange was renamed NASDAQ OMX Armenia.

The European Bank for Reconstruction and Development is one of the biggest investors in Armenia. The EBRD has implemented 136 projects with investments totaling €803 million since it started operating in the country in 1992. –0–

spot_img

POPULAR

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img